Metabolic management following bariatric surgery

Mount Sinai Journal of Medicine

Volumn 77, Issue 5, 2010, Pages 431-445

  Strohmayer, Erika ^a   Via, Michael A ^b   Yanagisawa, Robert ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

bariatric surgery; laparoscopic band surgery; malabsorptive bariatic surgery; metabolic management; postoperative malnutrition; Roux en Y gastric bypass

Indexed keywords

ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; CYANOCOBALAMIN; ESTRADIOL; FOLIC ACID; INSULIN; IRON; ORAL ANTIDIABETIC AGENT; OXALIC ACID; RETINOL; SELENIUM; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VITAMIN D; VITAMIN K GROUP; ZINC;

ALPHA TOCOPHEROL DEFICIENCY; ASCORBIC ACID DEFICIENCY; BARIATRIC SURGERY; BONE METABOLISM; COPPER DEFICIENCY; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; ERECTILE DYSFUNCTION; FOLIC ACID DEFICIENCY; GASTROPLASTY; HUMAN; IRON DEFICIENCY; IRON THERAPY; NEPHROLITHIASIS; OBESITY; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE CARE; PROTEIN CALORIE MALNUTRITION; PYRIDOXINE DEFICIENCY; RETINOL DEFICIENCY; REVIEW; SECONDARY HYPERPARATHYROIDISM; SELENIUM DEFICIENCY; STOMACH BYPASS; THIAMINE DEFICIENCY; ULCER; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ZINC DEFICIENCY;

BARIATRIC SURGERY; HUMANS; METABOLIC DISEASES; MICRONUTRIENTS; NUTRITION ASSESSMENT; OBESITY; POSTOPERATIVE CARE; VITAMINS;

EID: 78449251736     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20211     Document Type: Review

References (123)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR., Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235 - 241.
2. Adams TD, Gress RE, Smith SC, et al., Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753 - 761.
3. Sjöström L, Narbro K, Sjöström CD, et al., Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741 - 752.
4. Sjöström L., Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008; 32 (suppl 7): S93 - S97.
5. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55 (suppl 2): 615S - 619S.
6. Santry HP, Gillen DL, Lauderdale DS., Trends in bariatric surgical procedures. JAMA 2005; 294: 1909 - 1917.
7. Herron DM, Tong W., Role of surgery in management of type 2 diabetes mellitus. Mt Sinai J Med 2009; 76: 281 - 293.
8. Buchwald H, Estok R, Fahrbach K, et al., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248 - 256.e5.
9. Mechanick JI, Kushner RF, Sugerman HJ, et al., American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring) 2009; 17 (suppl 1): S1 - S70, v.
10. Stocker DJ., Management of the bariatric surgery patient. Endocrinol Metab Clin North Am 2003; 32: 437 - 457.
11. Ribeiro AG, Costa MJ, Faintuch J, Dias MC., A higher meal frequency may be associated with diminished weight loss after bariatric surgery. Clinics (Sao Paulo) 2009; 64: 1053 - 1058.
12. Apovian CM, Cummings S, Anderson W, et al., Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring) 2009; 17: 871 - 879.
13. Mechanick JI, Kushner RF, Sugerman HJ, et al., American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient [published correction appears in Surg Obes Relat Dis 2010; 6: 112]. Surg Obes Relat Dis 2008; 4 (5 suppl): S109 - S184.
14. Mallory GN, Macgregor AM, Rand CS., The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 1996; 6: 474 - 478.
15. Tack J, Arts J, Caenepeel P, et al., Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6: 583 - 590.
16. Bloomberg RD, Fleishman A, Nalle JE, et al., Nutritional deficiencies following bariatric surgery: what have we learned ? Obes Surg 2005; 15: 145 - 154.
17. Malinowski SS., Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 2006; 331: 219 - 225.
18. Faintuch J, Matsuda M, Cruz ME, et al., Severe protein-calorie malnutrition after bariatric procedures. Obes Surg 2004; 14: 175 - 181.
19. Brolin RE, LaMarca LB, Kenler HA, Cody RP., Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195 - 205.
20. Skroubis G, Sakellaropoulos G, Pouggouras K, et al., Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551 - 558.
21. Marceau S, Biron S, Lagacé M, et al., Biliopancreatic diversion, with distal gastrectomy, 250 cm and 50 cm limbs: long-term results. Obes Surg 1995; 5: 302 - 307.
22. Marinari GM, Murelli F, Camerini G, et al., A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg 2004; 14: 325 - 328.
23. Bock MA., Roux-en-Y gastric bypass: the dietitian's and patient's perspectives. Nutr Clin Pract 2003; 18: 141 - 144.
24. Alvarez-Leite JI., Nutrient deficiencies secondary to bariatric surgery. Curr Opin Clin Nutr Metab Care 2004; 7: 569 - 575.
25. Fujioka K., Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005; 28: 481 - 484.
26. Ernst B, Thurnheer M, Schmid SM, Schultes B., Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66 - 73.
27. Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ., Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg 2008; 18: 870 - 876.
28. Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ., Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part B: minerals. Obes Surg 2008; 18: 1028 - 1034.
29. Agte V, Tarwadi K, Mengale S, et al., Vitamin profile of cooked foods: how healthy is the practice of ready-to-eat foods ? Int J Food Sci Nutr 2002; 53: 197 - 208.
30. Markison S., The role of taste in the recovery from specific nutrient deficiencies in rats. Nutr Neurosci 2001; 4: 1 - 14.
31. Abbasi AA, Amin M, Smiertka JK, et al., Abnormalities of vitamin D and calcium metabolism after surgical treatment of morbid obesity: a study of 136 patients. Endocr Pract 2007; 13: 131 - 136.
32. Bischof MG, Heinze G, Vierhapper H., Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66: 211 - 215.
33. Carlin AM, Rao DS, Meslemani AM, et al., Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98 - 104.
34. Coupaye M, Puchaux K, Bogard C, et al., Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg 2009; 19: 56 - 65.
35. De Luis DA, Pacheco D, Izaola O, et al., Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab 2008; 53: 234 - 239.
36. Marceau P, Hould FS, Lebel S, et al., Malabsorptive obesity surgery. Surg Clin North Am 2001; 81: 1113 - 1127.
37. Rhode BM, Tamin H, Gilfix BM, et al., Treatment of vitamin B12 deficiency after gastric surgery for severe obesity. Obes Surg 1995; 5: 154 - 158.
38. Clements RH, Katasani VG, Palepu R, et al., Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 2006; 72: 1196 - 1204.
39. Johnson JM, Maher JW, DeMaria EJ, et al., The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 2006; 243: 701 - 705.
40. Coates PS, Fernstrom JD, Fernstrom MH, et al., Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004; 89: 1061 - 1065.
41. DiGiorgi M, Daud A, Inabnet WB, et al., Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg 2008; 18: 1144 - 1148.
42. Goldner WS, O'Dorisio TM, Dillon JS, Mason EE., Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 2002; 12: 685 - 692.
43. Johnson JM, Maher JW, Samuel I, et al., Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005; 9: 1106 - 1111.
44. Ott MT, Fanti P, Malluche HH, et al., Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992; 2: 341 - 348.
45. Fleischer J, Stein EM, Bessler M, et al., The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008; 93: 3735 - 3740.
46. Dixon JB, Strauss BJ, Laurie C, O'Brien PE., Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring) 2007; 15: 1187 - 1198.
47. Strauss BJ, Marks SJ, Growcott JP, et al., Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetol 2003; 40 (suppl 1): S266 - S269.
48. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, Tinoco RC., Calcium metabolism in pre-and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2004; 14: 1062 - 1066.
49. Hamoui N, Anthone G, Crookes PF., Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 9 - 12.
50. Wortsman J, Matsuoka LY, Chen TC, et al., Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690 - 693.
51. Jin J, Robinson AV, Hallowell PT, et al., Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery 2007; 142: 914 - 920.
52. Youssef Y, Richards WO, Sekhar N, et al., Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007; 21: 1393 - 1396.
53. Einarsdóttir K, Preen DB, Clay TD, et al., Effect of a single 'megadose' intramuscular vitamin D (600,000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg 2010; 20: 732 - 737.
54. Collazo-Clavell ML, Jimenez A, Hodgson SF, Sarr MG., Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 2004; 10: 195 - 198.
55. De Prisco C, Levine SN., Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005; 329: 57 - 61.
56. Miller AD, Smith KM., Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006; 63: 1852 - 1857.
57. Recker RR., Calcium absorption and achlorhydria. N Engl J Med 1985; 313: 70 - 73.
58. Duffey BG, Pedro RN, Makhlouf A, et al., Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg 2008; 206: 1145 - 1153.
59. Park AM, Storm DW, Fulmer BR, et al., A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol 2009; 182: 2334 - 2339.
60. Sinha MK, Collazo-Clavell ML, Rule A, et al., Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007; 72: 100 - 107.
61. Matlaga BR, Shore AD, Magnuson T, et al., Effect of gastric bypass surgery on kidney stone disease. J Urol 2009; 181: 2573 - 2577.
62. Nasr SH, D'Agati VD, Said SM, et al., Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3: 1676 - 1683.
63. Nelson WK, Houghton SG, Milliner DS, et al., Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 481 - 485.
64. Penniston KL, Kaplon DM, Gould JC, Nakada SY., Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol 2009; 182: 2340 - 2346.
65. Pories WJ, Caro JF, Flickinger EG, et al., The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 1987; 206: 316 - 323.
66. Pories WJ, Swanson MS, MacDonald KG, et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339 - 352.
67. Sugerman HJ, Wolfe LG, Sica DA, Clore JN., Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751 - 758.
68. MacDonald KG Jr., Long SD, Swanson MS, et al., The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213 - 220.
69. Scopinaro N, Marinari GM, Camerini GB, et al., Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005; 28: 2406 - 2411.
70. Scopinaro N, Papadia F, Camerini G, et al., A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg 2008; 18: 1035 - 1038.
71. Abbatini F, Rizzello M, Casella G, et al., Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24: 1005 - 1010.
72. Schauer PR, Burguera B, Ikramuddin S, et al., Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467 - 485.
73. Torquati A, Lutfi R, Abumrad N, Richards WO., Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients ? J Gastrointest Surg 2005; 9: 1112 - 1118.
74. Vidal J, Ibarzabal A, Romero F, et al., Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077 - 1082.
75. Sjöström L, Lindroos AK, Peltonen M, et al., Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683 - 2693.
76. Dixon JB, O'Brien PE, Playfair J, et al., Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316 - 323.
77. O'Brien PE, Dixon JB, Laurie C, et al., Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144: 625 - 633.
78. Marceau P, Biron S, Hould FS, et al., Duodenal switch: long-term results. Obes Surg 2007; 17: 1421 - 1430.
79. Marinari GM, Papadia FS, Briatore L, et al., Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. Obes Surg 2006; 16: 1440 - 1444.
80. Tice JA, Karliner L, Walsh J, et al., Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885 - 893.
81. 2. J Gastrointest Surg 2008; 12: 945 - 952.
82. Salinari S, Bertuzzi A, Asnaghi S, et al., First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 2009; 32: 375 - 380.
83. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK., Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 1098 - 1103.
84. Kashyap SR, Daud S, Kelly KR, et al., Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010; 34: 462 - 471.
85. Wickremesekera K, Miller G, Naotunne TD, et al., Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474 - 481.
86. Thaler JP, Cummings DE., Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518 - 2525.
87. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK., Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401 - 407.
88. Cummings DE, Weigle DS, Frayo RS, et al., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623 - 1630.
89. Peterli R, Wölnerhanssen B, Peters T, et al., Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234 - 241.
90. Dronge AS, Perkal MF, Kancir S, et al., Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141: 375 - 380.
91. Reis LO, Favaro WJ, Barreiro GC, et al., Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. Int J Androl 2009;doi:10.1111/j.1365-2605.2010.01097.x.
92. Habib ZA, Havstad SL, Wells K, et al., Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2010; 95: 592 - 600.
93. Franks S, White DM., Prevalence of and etiological factors in polycystic ovarian syndrome. Ann N Y Acad Sci 1993; 687: 112 - 114. (Pubitemid 23217930)
94. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE., Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929 - 1935.
95. Kronenberg H, Williams RH., Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders/Elsevier; 2008.
96. Hoeger KM, Kochman L, Wixom N, et al., A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004; 82: 421 - 429.
97. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al., The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005; 90: 6364 - 6369.
98. Eid GM, Cottam DR, Velcu LM, et al., Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 77 - 80.
99. Collins J, Mattar S, Qureshi F, et al., Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis 2007; 3: 147 - 152.
100. Teitelman M, Grotegut CA, Williams NN, Lewis JD., The impact of bariatric surgery on menstrual patterns. Obes Surg 2006; 16: 1457 - 1463.
101. Bilenka B, Ben-Shlomo I, Cozacov C, et al., Fertility, miscarriage and pregnancy after vertical banded gastroplasty operation for morbid obesity. Acta Obstet Gynecol Scand 1995; 74: 42 - 44.
102. Deitel M, Stone E, Kassam HA, et al., Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 1988; 7: 147 - 153.
103. Merhi ZO., Impact of bariatric surgery on female reproduction. Fertil Steril 2009; 92: 1501 - 1508.
104. Haddow JE, Hill LE, Kloza EM, Thanhauser D., Neural tube defects after gastric bypass. Lancet 1986; 1: 1330.
105. Maggard MA, Yermilov I, Li Z, et al., Pregnancy and fertility following bariatric surgery: a systematic review. JAMA 2008; 300: 2286 - 2296.
106. Smith J, Cianflone K, Biron S, et al., Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 2009; 94: 4275 - 4283.
107. Martin LF, Finigan KM, Nolan TE., Pregnancy after adjustable gastric banding. Obstet Gynecol 2000; 95: 927 - 930.
108. Diaz-Arjonilla M, Schwarcz M, Swerdloff RS, Wang C., Obesity, low testosterone levels and erectile dysfunction. Int J Impot Res 2009; 21: 89 - 98.
109. Hammoud AO, Wilde N, Gibson M, et al., Male obesity and alteration in sperm parameters. Fertil Steril 2008; 90: 2222 - 2225.
110. Sallmen M, Sandler DP, Hoppin JA, et al., Reduced fertility among overweight and obese men. Epidemiology 2006; 17: 520 - 523.
111. Leenen R, van der Kooy K, Seidell JC, et al., Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994; 78: 1515 - 1520.
112. Niskanen L, Laaksonen DE, Punnonen K, et al., Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004; 6: 208 - 215.
113. Kaukua J, Pekkarinen T, Sane T, Mustajoki P., Sex hormones and sexual function in obese men losing weight. Obes Res 2003; 11: 689 - 694.
114. Esposito K, Giugliano F, Di Palo C, et al., Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978 - 2984.
115. Esposito K, Ciotola M, Giugliano F, et al., Effects of intensive lifestyle changes on erectile dysfunction in men. J Sex Med 2009; 6: 243 - 250.
116. Hammoud A, Gibson M, Hunt SC, et al., Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 2009; 94: 1329 - 1332.
117. Alagna S, Cossu ML, Gallo P, et al., Biliopancreatic diversion: long-term effects on gonadal function in severely obese men. Surg Obes Relat Dis 2006; 2: 82 - 86.
118. Bastounis EA, Karayiannakis AJ, Syrigos K, et al., Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. Eur Surg Res 1998; 30: 43 - 47.
119. Omana JJ, Tamler R, Strohmayer E, et al., Sex hormone levels in men undergoing bariatric surgery. J Am Coll Surg 2009; 209 (suppl 1): S22 - S23.
120. Dallal RM, Chernoff A, O'Leary MP, et al., Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery. J Am Coll Surg 2008; 207: 859 - 864.
121. Di Frega AS, Dale B, Di Matteo L, Wilding M., Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report. Hum Reprod 2005; 20: 997 - 998.
122. Gehrer S, Kern B, Peters T, et al., Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB): a prospective study. Obes Surg 2010; 20: 447 - 453.
123. Ledoux S, Msika S, Moussa F, et al., Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg 2006; 16: 1041 - 1049.